期刊文献+

凋亡抑制基因survivin在膀胱癌组织中的表达

The expression of antiapoptosis survivin in bladder carcinoma
下载PDF
导出
摘要 目的探讨新的凋亡抑制基因survivin在膀胱癌组织中的表达及其与膀胱癌生物学特性的相关性。方法应用免疫组织化学链霉素抗生物素蛋白-过氧化酶连接法(SP),检测survivin在42例膀胱癌组织、8例正常膀胱组织中的表达。结果Survivin在正常膀胱组织中不表达;42例膀胱癌组织有28例表达阳性,阳性率为66.7%。病理分级Ⅰ-Ⅲ级膀胱癌survivin阳性表达率分别为33.3%、76.2%、88.9%,差别有统计学意义(P<0.05);临床分期T1-T3期膀胱癌的阳性表达率分别为60.9%(14/23)、66.7%(8/12)、85.7%(6/7),差别无统计学意义(P>0.05);无复发与有复发膀胱癌的阳性表达率分别为53.8%(14/26)、87.5%(14/16),差别有统计学意义(P<0.05)。结论Survivin阳性表达引起的细胞凋亡抑制在膀胱癌的发生、发展中起一定作用,其过度表达可能提示膀胱癌预后不良。 Objective To study the expression of a novel inhibitor of apoptosis, survivin, in bladder carcinoma and its relationship with biological characteristic of bladder carcinoma. Methods Using streptavidin-biotin peroxidase (SP) method, we examined the expression of survivin in 8 normal vesical and 42 bladder carcinoma tissues, Results Survivin was expressed in 28 of the 42 (66.7%) cases of bladder carcinomas but was not expressed in normal bladder epithelium. The positive rate of survivin in grade I, grade II and grade III was 33.3%, 76.2% and 88.9% respectively, and the difference was significant ( P〈 0.01). The positive rate of survivin in T1, T2, and T3 was 60.9%, 66, 7% and 85.7%, respectively, and the difference wasn't significant (P〉0.05). The positive rate of survivin in recurrent and non-recurrent group was 53.8 % and 87,5 %, respectively, and the difference was significant (P〈0.01). Conclusion Apoptosis inhibited by survivin may participate in the onset and progression, The overexpression of survivin may suggest the poor prognosis of bladder carcinoma.
出处 《现代泌尿外科杂志》 CAS 2006年第5期259-261,共3页 Journal of Modern Urology
关键词 SURVIVIN 膀胱 移行细胞癌 免疫组织化学 survivin bladder transitional cell carcinoma immunohistochemistry
  • 相关文献

参考文献7

  • 1Ambrosini G,Adida C,Altieri DC.A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma[J].Nat Med,1997,3:917-921.
  • 2Adida C,Crotty PL,Mograth J,et al.Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation[J].Am J Pathol,1998,152:43-49.
  • 3Li F,Ambrosini G,Chu EY,et al.Control of apoptosis and mitotic spindle checkpoint by survivin[J].Nature,1998,396:580-584.
  • 4Suzuki A,Ito K,Kawano H,et al.Survivin initiates ptrocapase 3/P21 complex formation as a result of interaction with CDK4 to resist Fas-mediated cell death[J].Oncogene,2000,19:1346-1353.
  • 5Swana HS,Grossman D,Anthony JN,et al.Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer[J].N Engl J Med,1999,341:452-453.
  • 6王梅,王冰,王晓丽,莫立平,任娟,李明众.凋亡相关基因survivin在子宫颈癌组织中的表达及其与bcl-2、p53基因表达相关性的初步研究[J].中华妇产科杂志,2001,36(9):546-548. 被引量:76
  • 7Sharp JD,Hausladen DA,Maher MG,et al.Bladder cancer detection with urinary survivin,an inhibitor of apoptosis[J].Front Biosci,2002,7:36-41.

二级参考文献4

  • 1Grossman D,J Invest Dermatol,1999年,113卷,1076页
  • 2Grossman D,Lab Invest,1999年,79卷,1121页
  • 3Li F,Nature,1998年,396卷,580页
  • 4Deveraux Q L,Nature,1997年,388卷,300页

共引文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部